Compare VNRX & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VNRX | LCFY |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 8.3M |
| IPO Year | 2012 | 2021 |
| Metric | VNRX | LCFY |
|---|---|---|
| Price | $0.17 | $1.18 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.62 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 57.1K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $57.67 | N/A |
| Revenue Next Year | $240.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $1.20 |
| 52 Week High | $3.26 | $6.20 |
| Indicator | VNRX | LCFY |
|---|---|---|
| Relative Strength Index (RSI) | 22.79 | 24.39 |
| Support Level | $0.15 | N/A |
| Resistance Level | $0.18 | $2.75 |
| Average True Range (ATR) | 0.02 | 0.24 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 0.32 | 7.74 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.